India Globalization Capital, Inc.  

(Public, NYSEMKT:IGC)   Watch this stock  
Find more results for NYSEAMEX:IGC
0.510
+0.010 (2.00%)
Jul 26 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.50 - 0.55
52 week 0.14 - 0.83
Open 0.50
Vol / Avg. 65,282.00/109,246.00
Mkt cap 11.02M
P/E     -
Div/yield     -
EPS -0.17
Shares 23.34M
Beta 4.30
Inst. own 1%
Aug 15, 2016
Q1 2017 India Globalization Capital Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 18, 2016
Q4 2016 India Globalization Capital Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2016
Net profit margin -102.02% -44.51%
Operating margin -129.09% -45.64%
EBITD margin - -29.21%
Return on average assets -30.04% -14.46%
Return on average equity -42.99% -20.27%
Employees 31 -
CDP Score - -

Address

4336 Montgomery Ave
BETHESDA, MD 20814-4443
United States - Map
+1-301-9830998 (Phone)
+1-240-4650273 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

India Globalization Capital, Inc. (IGC) focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies for end of life supportive care, hospice care, and chronic neurological and oncological diagnosis. Through an overseas division it also supplies components for original equipment manufacturers (OEMs) involved in healthcare and the Internet-of-things.

Officers and directors

Ram Mukunda Executive Chairman of the Board, Chief Executive Officer, Founder
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John R. Clarke Interim Principal Financial & Accounting Officer and Treasurer
Age: 48
Bio & Compensation  - Reuters
Richard K. Prins Independent Director
Age: 57
Bio & Compensation  - Reuters
Sudhakar V. Shenoy Independent Director
Age: 67
Bio & Compensation  - Reuters